Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis

The treatments for multiple sclerosis (MS) have improved over the past 25 years, but now the main question for physicians is deciding who should receive treatment, for how long, and when to switch to other options. These decisions are typically based on treatment tolerance and a reasonable expectati...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	EXCLI journal 2021-01, Vol.20, p.1308-1325
Hauptverfasser:	Kouchaki, Ebrahim, Dashti, Fatemeh, Mirazimi, Seyed Mohammad Ali, Alirezaei, Zahra, Jafari, Seyed Hamed, Hamblin, Michael R, Mirzaei, Hamed
Format:	Artikel
Sprache:	eng
Schlagworte:	Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!